You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

Citation Tools

Article menu
Download PDFPDF
ABSTRACT: Oral Poster Presentations: Cervical Cancer Tuesday, October 17, 2006
0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mirza MR, Depont R, Lund B, et al
0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)
International Journal of Gynecologic Cancer 2006;16:620.